Status:

UNKNOWN

Accessible Cancer Care to Enable Support for Survivors Programme

Lead Sponsor:

National University of Singapore

Collaborating Sponsors:

National Cancer Centre, Singapore

Conditions:

Survivorship

Breast Cancer

Eligibility:

FEMALE

21+ years

Phase:

NA

Brief Summary

In Singapore, cancer patients are not consistently assessed for unmet survivorship care needs and systematically identified for subsequent referral to useful care services. To address this gap, a prel...

Detailed Description

A cluster randomized controlled trial will be conducted at the National Cancer Centre Singapore (NCCS) over a period of 2 years. Eligible participants and their caregivers where applicable will be rec...

Eligibility Criteria

Inclusion

  • Confirmed diagnosis of breast or gynaecological cancer ascertained by clinical documentation
  • Newly diagnosed patients receiving subsequent follow-up care in NCCS
  • Able to read and understand English or Chinese
  • Capable of providing informed consent

Exclusion

  • Physically or mentally incapable of providing verbal / written consent
  • Patients under active care by the palliative care team

Key Trial Info

Start Date :

October 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2021

Estimated Enrollment :

226 Patients enrolled

Trial Details

Trial ID

NCT04014309

Start Date

October 1 2019

End Date

October 1 2021

Last Update

November 29 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Cancer Centre Singapore

Singapore, Singapore